Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity
| Autor: | Ajgal, Z. a, ⁎, de Percin, S. a, Diéras, V. b, Pierga, J.Y. b, Campana, F. a, Fourquet, A. a, Kirova, Y.M. a |
|---|---|
| Zdroj: | In Cancer / Radiothérapie April 2017 21(2):114-118 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect